Anokion
Anokion is a Switzerland-based biotechnology company that researches and develops antigen-specific immune tolerance therapies for the treatment of autoimmune diseases.
Business Model:
Revenue: $5M
Employees: 11-50
Industries / Tags:
Detailed Anokion Information
Geographic Data
Address: EPFL Innovation Park-L
City: Ecublens
State: vaud
Zip: 1024
Country: CH
Financial Info
Stage:
series b
Raised Last:
$40M
Raised Total:$78M
Social
Metrics
3,328,811Website Global Rank
4,502Website Monthly Traffic
Twitter Followers
Description
Anokion is a Switzerland-based biotechnology company that researches and develops antigen-specific immune tolerance therapies for the treatment of autoimmune diseases.
Contact Phone:
+18573206607
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2022 | Equity | $35M |
Pfizer Inc. |
10/2022 | Venture Round | 1 | $35M |
Pfizer Breakthrough Growth Initiative Pfizer Breakthrough Growth Initiative |
5/2014 | Series A | 5 | $37.5M |
André J. Mueller Harry Welten Novartis Venture Fund Novo Ventures Versant Ventures André J. Mueller Harry Welten Novartis Venture Fund Novo Ventures Versant Ventures |
12/2011 | Debt Financing | 1 | $106.9k |
Foundation for Technological Innovation (FIT) Foundation for Technological Innovation (FIT) |
9/2019 | Series B | 4 | $40M |
Celgene Novartis Venture Fund Novo Ventures Versant Ventures Celgene Novartis Venture Fund Novo Ventures Versant Ventures |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 9/2019 | Kanyos Bio |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
